Thyroid Gland Oncocytic Carcinoma — Trials

Thyroid Gland Oncocytic Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

12 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 4
Recruiting: 2
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: Alliance for Clinical Trials in Oncology
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05410821	Evaluation of 177Lu-DOTA-EB-FAPI in Patients With Metastatic Radioactive Iodine Refractory Thyroid Cancer	completed	Phase 1	12	The First Affiliated Hospital of Xiamen UniversityOTHER	1	Apr 1, 2025	clinicaltrials
NCT01208051	Cediranib Maleate With or Without Lenalidomide for the Treatment of Thyroid Cancer	completed	Phase 1 / Phase 2	127	National Cancer Institute (NCI)NIH	2	Jul 15, 2021	clinicaltrials